脊椎内視鏡手術のグローバル市場(2021〜2031):内視鏡、内視鏡装置

■ 英語タイトル:Endoscopic Spinal Surgery Market By Product Type (Endoscopes, Endoscopic Devices), By Procedure type (Transforaminal Endoscopic Procedures, Interlaminar Endoscopic Procedures, Endoscopic Posterior Foraminotomy and Cervical Discectomy, Endoscopic Visualized Rhizotomy), By End User (Hospital and Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート(データ管理コード:ALD23FB184)■ 発行会社/調査会社:Allied Market Research
■ 商品コード:ALD23FB184
■ 発行日:2022年10月
■ 調査対象地域:グローバル
■ 産業分野:医療
■ ページ数:236
■ レポート言語:英語
■ レポート形式:PDF
■ 納品方式:Eメール(受注後24時間以内)
■ 販売価格オプション(消費税別)
Online Only(1名閲覧、印刷不可)USD3,570 ⇒換算¥542,640見積依頼/購入/質問フォーム
Single User(1名閲覧)USD5,730 ⇒換算¥870,960見積依頼/購入/質問フォーム
Enterprise User(閲覧人数無制限)USD9,600 ⇒換算¥1,459,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能)
Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[脊椎内視鏡手術のグローバル市場(2021〜2031):内視鏡、内視鏡装置]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Allied Market Research社の本市場調査レポートでは、2021年に536.9百万ドルであった世界の脊椎内視鏡手術市場規模が、2031年までに1,096.31百万ドルに到達し、2022年から2031年にかけてCAGR(年平均成長率)7.4%で成長すると予測しています。本レポートは、脊椎内視鏡手術の世界市場を総合的に調査・分析した資料であり、イントロダクション、エグゼクティブサマリー、市場概要、製品別(内視鏡、内視鏡装置)分析、手術別(経椎間孔内視鏡手術、層間内視鏡手術、内視鏡的後孔切除術・頸椎椎間板切除術、内視鏡可視化根茎切開術)分析、エンドユーザー別(病院・診療所、外来手術センター)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ)分析、企業状況、企業情報などを掲載しています。また、本レポートは、DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)、MEDTRONIC PLC.、MEDICALTEK CO., LTD.、STRYKER CORPORATION、ZIMMER BIOMET HOLDINGS, INC.などの企業情報を含んでいます。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の脊椎内視鏡手術市場規模:製品別
- 内視鏡における市場規模
- 内視鏡装置における市場規模
・世界の脊椎内視鏡手術市場規模:手術別
- 経椎間孔内視鏡手術の市場規模
- 層間内視鏡手術の市場規模
- 内視鏡的後孔切除術・頸椎椎間板切除術の市場規模
- 内視鏡可視化根茎切開術の市場規模
・世界の脊椎内視鏡手術市場規模:地域別
- 北米の脊椎内視鏡手術市場規模
- ヨーロッパの脊椎内視鏡手術市場規模
- アジア太平洋の脊椎内視鏡手術市場規模
- 中南米・中東・アフリカの脊椎内視鏡手術市場規模
・企業状況
・企業情報

世界の脊椎内視鏡手術市場は、2021年には5億3,690万ドルと評価され、2022年から2031年までの年平均成長率は7.4%を記録し、2031年には10億9,631万ドルに達すると予測されています。

脊椎内視鏡手術(ESS)は、1インチ以下の極小切開創と内視鏡と一緒に小さな管状システムを使用して、人体の内部器官の鮮明な画像を取得する外科手術を指します。この種の脊椎手術は、ESSが提供する光学の進歩、組織の質の高い可視化、効率的な脊椎画像診断のおかげで、現在多くの患者の治療の選択肢となっています。また、この手術は低侵襲手術の一つであり、術後の回復が早いという利点もあります。さらに、この手術では管状レトラクタと内視鏡を使用するため、内臓を間接的に可視化することができます。さらに、手術中の間接的な可視化は、多くの異なる外科専門分野にわたって、従来の直接的な可視化に取って代わり、脊椎内視鏡手術の需要をさらに高めています。

世界保健機関(WHO)によると、2030年には世界中で約10億人の高齢者が増えると予想されており、これは総人口の12%に相当します。高齢者人口の割合は、その後の20年間も増加し続けると予想されています。2050年には、世界の高齢者人口は16億人になり、世界総人口94億人の16.7%を占めると推定されています。さらに、いくつかの研究によると、高齢者は腰痛や脊椎関節炎など、加齢に関連した慢性疾患にかかりやすく、特別な治療が必要になる可能性があると報告されています。

このような高齢者人口の増加が予想されることから、痛みが少なく回復が早い脊椎内視鏡手術が治療の選択肢として需要が高まり、予測期間中の市場拡大にさらにつながります。
また、強直性脊椎炎、脊柱管狭窄症、椎間板ヘルニア、血腫、椎間板変性疾患、椎体骨折などの脊椎疾患の症例が増加しています。ジョンズ・ホプキンス関節炎センターによると、最近の人口推計では、米国における強直性脊椎炎(AS)の有病率は約0.2~0.5%であり、複数の国のデータに基づくと、強直性脊椎炎(AS)の年齢・性別調整後の発症率は人口10万人当たり0.4~14人です。また、1年間に椎間板ヘルニアになる人は約2%です。このように、世界中で脊椎疾患の有病率は非常に高く、脊椎内視鏡手術の需要も増加しており、手術に関連する器具の採用を後押ししています。これが脊椎内視鏡手術市場の成長をさらに後押ししています。

さらに、この分野での技術の進歩により、医療提供者だけでなく患者の間でもこの技術の採用が増加しています。脊椎手術の複雑さは、手術中に重大な障害を引き起こし、手術の効果を低下させる可能性があります。さらに、3D内視鏡の使用により、損傷のリスクが減少し、手術の精度が向上しました。例えば、Mazor Robotics社が開発した3D解析、高度なアルゴリズム、患者接続プラットフォーム、クロスモダリティ画像登録など4つの主要技術を組み合わせた高精度な脊椎内視鏡手術の導入。さらに、政府やその他の組織は、医療施設の発展をもたらすために、特定の地域で研究開発活動を開始するための資金を提供しています。これも市場の成長を加速させています。

さらに、低侵襲脊椎手術の採用の増加、脊椎疾患の有病率の増加、世界的な高齢者人口の増加などの要因も市場の成長を促進します。市場の成長を促進する要因は数多くありますが、脊椎内視鏡手術に関連する高額な費用や、新興地域における適切な償還政策の欠如が市場の成長を妨げています。

脊椎内視鏡手術市場は、製品タイプ、処置タイプ、エンドユーザー、地域に基づいて調査されます。製品タイプ別では、市場は内視鏡と内視鏡デバイスに区分されます。処置タイプ別では、経鏡的内視鏡術、層間内視鏡術、内視鏡的後方椎弓切除術&頸椎椎間板切除術、内視鏡的可視化根切術に分類されます。エンドユーザー別では、病院&クリニックと外来手術センターに分類されます。地域別では、北米、欧州、アジア太平洋、LAMEAに市場を分けて分析しています。

本レポートに掲載されている主要企業には、Endovision Co. Ltd.、Globus Medical Inc.、Jiomax Inc.、Johnson & Johnson (Depuy Synthes Spine, Inc.)、Karl Storz Se & Co. Kg、Medtronic Plc.、Medicaltek Co.Ltd.、オリンパス株式会社、Richard Wolf、Stryker Corporation、Zimmer Biomet Holdings, Inc.などがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの脊椎内視鏡手術市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、優勢な脊椎内視鏡手術市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
・脊椎内視鏡手術市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・脊椎内視鏡手術の地域別および世界市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
製品タイプ別
内視鏡
内視鏡デバイス

処置タイプ別
経鏡的内視鏡手術
椎間孔内視鏡下手術
内視鏡下後椎弓切除術&頸椎椎間板切除術
内視鏡下視索切開術

エンドユーザー別
病院・診療所
外来手術センター

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
MEDTRONIC PLC.
MEDICALTEK CO., LTD.
STRYKER CORPORATION
ZIMMER BIOMET HOLDINGS, INC.
オリンパス株式会社
KARL STORZ SE & CO. KG
Richard Wolf GmbH
GLOBUS MEDICAL INC.
Endovision Co., Ltd.
joimax GmbH

世界の市場調査レポート販売サイト(H&Iグローバルリサーチ株式会社運営)
*** レポート目次(コンテンツ)***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Endoscopes
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3 Endoscopic Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2 Transforaminal Endoscopic Procedures
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3 Interlaminar Endoscopic Procedures
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
5.4 Endoscopic Posterior Foraminotomy and Cervical Discectomy
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market share analysis by country
5.5 Endoscopic Visualized Rhizotomy
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market share analysis by country
CHAPTER 6: ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Hospital and Clinics
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3 Ambulatory Surgical Centers
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
CHAPTER 7: ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Product Type
7.2.3 North America Market size and forecast, by Procedure type
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Product Type
7.2.5.1.3 Market size and forecast, by Procedure type
7.2.5.1.4 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Product Type
7.2.5.2.3 Market size and forecast, by Procedure type
7.2.5.2.4 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Product Type
7.2.5.3.3 Market size and forecast, by Procedure type
7.2.5.3.4 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Product Type
7.3.3 Europe Market size and forecast, by Procedure type
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Product Type
7.3.5.1.3 Market size and forecast, by Procedure type
7.3.5.1.4 Market size and forecast, by End User
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Product Type
7.3.5.2.3 Market size and forecast, by Procedure type
7.3.5.2.4 Market size and forecast, by End User
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Product Type
7.3.5.3.3 Market size and forecast, by Procedure type
7.3.5.3.4 Market size and forecast, by End User
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Product Type
7.3.5.4.3 Market size and forecast, by Procedure type
7.3.5.4.4 Market size and forecast, by End User
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Product Type
7.3.5.5.3 Market size and forecast, by Procedure type
7.3.5.5.4 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Product Type
7.3.5.6.3 Market size and forecast, by Procedure type
7.3.5.6.4 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Product Type
7.4.3 Asia-Pacific Market size and forecast, by Procedure type
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 Japan
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Product Type
7.4.5.1.3 Market size and forecast, by Procedure type
7.4.5.1.4 Market size and forecast, by End User
7.4.5.2 China
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Product Type
7.4.5.2.3 Market size and forecast, by Procedure type
7.4.5.2.4 Market size and forecast, by End User
7.4.5.3 Australia
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Product Type
7.4.5.3.3 Market size and forecast, by Procedure type
7.4.5.3.4 Market size and forecast, by End User
7.4.5.4 India
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Product Type
7.4.5.4.3 Market size and forecast, by Procedure type
7.4.5.4.4 Market size and forecast, by End User
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Product Type
7.4.5.5.3 Market size and forecast, by Procedure type
7.4.5.5.4 Market size and forecast, by End User
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Product Type
7.4.5.6.3 Market size and forecast, by Procedure type
7.4.5.6.4 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Product Type
7.5.3 LAMEA Market size and forecast, by Procedure type
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Product Type
7.5.5.1.3 Market size and forecast, by Procedure type
7.5.5.1.4 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Product Type
7.5.5.2.3 Market size and forecast, by Procedure type
7.5.5.2.4 Market size and forecast, by End User
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Product Type
7.5.5.3.3 Market size and forecast, by Procedure type
7.5.5.3.4 Market size and forecast, by End User
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Product Type
7.5.5.4.3 Market size and forecast, by Procedure type
7.5.5.4.4 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON)
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 MEDTRONIC PLC.
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 MEDICALTEK CO., LTD.
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 STRYKER CORPORATION
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 ZIMMER BIOMET HOLDINGS, INC.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 OLYMPUS CORPORATION
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 KARL STORZ SE & CO. KG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 Richard Wolf GmbH
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 GLOBUS MEDICAL INC.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 Endovision Co., Ltd.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
9.11 joimax GmbH
9.11.1 Company overview
9.11.2 Company snapshot
9.11.3 Operating business segments
9.11.4 Product portfolio
9.11.5 Business performance
9.11.6 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 4. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 5. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC DEVICES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 6. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 7. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 8. ENDOSCOPIC SPINAL SURGERY MARKET FOR TRANSFORAMINAL ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 9. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. ENDOSCOPIC SPINAL SURGERY MARKET FOR INTERLAMINAR ENDOSCOPIC PROCEDURES, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 11. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC POSTERIOR FORAMINOTOMY AND CERVICAL DISCECTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 13. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 14. ENDOSCOPIC SPINAL SURGERY MARKET FOR ENDOSCOPIC VISUALIZED RHIZOTOMY, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 15. GLOBAL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 16. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 17. ENDOSCOPIC SPINAL SURGERY MARKET FOR HOSPITAL AND CLINICS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 18. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 19. ENDOSCOPIC SPINAL SURGERY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 20. ENDOSCOPIC SPINAL SURGERY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 21. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 22. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 24. NORTH AMERICA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 25. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 26. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. U.S. ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 28. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 29. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. CANADA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 31. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 32. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. MEXICO ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 34. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 35. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 37. EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 38. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 39. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. GERMANY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 41. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. FRANCE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 44. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. UK ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 48. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ITALY ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 50. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 51. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. SPAIN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 53. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 54. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. REST OF EUROPE ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 56. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 57. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 59. ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 60. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. JAPAN ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 63. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 64. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. CHINA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 66. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 67. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. AUSTRALIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 69. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 70. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. INDIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 72. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 73. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. SOUTH KOREA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 75. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 76. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. REST OF ASIA-PACIFIC ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 78. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 79. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 80. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 81. LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 82. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. BRAZIL ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 85. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 86. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 87. SAUDI ARABIA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 88. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 89. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 90. SOUTH AFRICA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 91. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PRODUCT TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 92. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY PROCEDURE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 93. REST OF LAMEA ENDOSCOPIC SPINAL SURGERY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
TABLE 94.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): COMPANY SNAPSHOT
TABLE 95.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): OPERATING SEGMENTS
TABLE 96.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): PRODUCT PORTFOLIO
TABLE 97.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): NET SALES
TABLE 98.DEPUY SYNTHES SPINE, INC. (JOHNSON & JOHNSON): KEY STRATERGIES
TABLE 99.MEDTRONIC PLC.: COMPANY SNAPSHOT
TABLE 100.MEDTRONIC PLC.: OPERATING SEGMENTS
TABLE 101.MEDTRONIC PLC.: PRODUCT PORTFOLIO
TABLE 102.MEDTRONIC PLC.: NET SALES
TABLE 103.MEDTRONIC PLC.: KEY STRATERGIES
TABLE 104.MEDICALTEK CO., LTD.: COMPANY SNAPSHOT
TABLE 105.MEDICALTEK CO., LTD.: OPERATING SEGMENTS
TABLE 106.MEDICALTEK CO., LTD.: PRODUCT PORTFOLIO
TABLE 107.MEDICALTEK CO., LTD.: NET SALES
TABLE 108.MEDICALTEK CO., LTD.: KEY STRATERGIES
TABLE 109.STRYKER CORPORATION: COMPANY SNAPSHOT
TABLE 110.STRYKER CORPORATION: OPERATING SEGMENTS
TABLE 111.STRYKER CORPORATION: PRODUCT PORTFOLIO
TABLE 112.STRYKER CORPORATION: NET SALES
TABLE 113.STRYKER CORPORATION: KEY STRATERGIES
TABLE 114.ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
TABLE 115.ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
TABLE 116.ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
TABLE 117.ZIMMER BIOMET HOLDINGS, INC.: NET SALES
TABLE 118.ZIMMER BIOMET HOLDINGS, INC.: KEY STRATERGIES
TABLE 119.OLYMPUS CORPORATION: COMPANY SNAPSHOT
TABLE 120.OLYMPUS CORPORATION: OPERATING SEGMENTS
TABLE 121.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
TABLE 122.OLYMPUS CORPORATION: NET SALES
TABLE 123.OLYMPUS CORPORATION: KEY STRATERGIES
TABLE 124.KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
TABLE 125.KARL STORZ SE & CO. KG: OPERATING SEGMENTS
TABLE 126.KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
TABLE 127.KARL STORZ SE & CO. KG: NET SALES
TABLE 128.KARL STORZ SE & CO. KG: KEY STRATERGIES
TABLE 129.RICHARD WOLF GMBH: COMPANY SNAPSHOT
TABLE 130.RICHARD WOLF GMBH: OPERATING SEGMENTS
TABLE 131.RICHARD WOLF GMBH: PRODUCT PORTFOLIO
TABLE 132.RICHARD WOLF GMBH: NET SALES
TABLE 133.RICHARD WOLF GMBH: KEY STRATERGIES
TABLE 134.GLOBUS MEDICAL INC.: COMPANY SNAPSHOT
TABLE 135.GLOBUS MEDICAL INC.: OPERATING SEGMENTS
TABLE 136.GLOBUS MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 137.GLOBUS MEDICAL INC.: NET SALES
TABLE 138.GLOBUS MEDICAL INC.: KEY STRATERGIES
TABLE 139.ENDOVISION CO., LTD.: COMPANY SNAPSHOT
TABLE 140.ENDOVISION CO., LTD.: OPERATING SEGMENTS
TABLE 141.ENDOVISION CO., LTD.: PRODUCT PORTFOLIO
TABLE 142.ENDOVISION CO., LTD.: NET SALES
TABLE 143.ENDOVISION CO., LTD.: KEY STRATERGIES
TABLE 144.JOIMAX GMBH: COMPANY SNAPSHOT
TABLE 145.JOIMAX GMBH: OPERATING SEGMENTS
TABLE 146.JOIMAX GMBH: PRODUCT PORTFOLIO
TABLE 147.JOIMAX GMBH: NET SALES
TABLE 148.JOIMAX GMBH: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/



※注目の調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD23FB184 )"脊椎内視鏡手術のグローバル市場(2021〜2031):内視鏡、内視鏡装置" (英文:Endoscopic Spinal Surgery Market By Product Type (Endoscopes, Endoscopic Devices), By Procedure type (Transforaminal Endoscopic Procedures, Interlaminar Endoscopic Procedures, Endoscopic Posterior Foraminotomy and Cervical Discectomy, Endoscopic Visualized Rhizotomy), By End User (Hospital and Clinics, Ambulatory Surgical Centers): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。